SCHEMBL31207902

SCHEMBL31207902

CCOC(=O)c1c(C)nc(SC)nc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.44
KDM4E B2RXH2 3/20 0.44
PKM P14618 1/20 0.44
MAPT P10636 5/20 0.44
TSHR P16473 3/20 0.44
ALDH1A1 P00352 3/20 0.43
HPGD P15428 3/20 0.43
NPSR1 Q6W5P4 2/20 0.43
GAA P10253 2/20 0.43
RAB9A P51151 2/20 0.43
NPC1 O15118 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
PDE4D Q08499 1/20 0.42
MAPK1 P28482 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
HTT P42858 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
ADORA3 P0DMS8 2/20 0.40
POLB P06746 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1298575 1.00 LMNA (0.44) LMNAKDM4EPKMMAPTTSHR
SCHEMBL31207901 1.00 LMNA (0.44) LMNAKDM4EPKMMAPTTSHR
SCHEMBL537829 0.94 MAPT (0.48) LMNAKDM4EPKMMAPTTSHR
SCHEMBL18305004 0.89 LMNA (0.49) LMNAKDM4EPKMMAPTTSHR
SCHEMBL9124409 0.86 MAPT (0.43) LMNAKDM4EPKMMAPTTSHR
SCHEMBL22573664 0.85 KDM4E (0.49) LMNAKDM4EPKMMAPTTSHR
SCHEMBL24785780 0.84 TSHR (0.42) LMNAKDM4ETSHRALDH1A1HPGD
SCHEMBL30558073 0.84 ALDH1A1 (0.41) LMNAKDM4EMAPTTSHRALDH1A1
SCHEMBL25366832 0.84 ALDH1A1 (0.41) LMNAKDM4EMAPTTSHRALDH1A1
SCHEMBL1298124 0.83 LMNA (0.44) LMNAKDM4EPKMMAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122074043-A Combination therapy with KRAS modulators 光达治疗公司 2026-05-22 CN disclosed
CN-119110804-A KRAS modulators and uses thereof 光达治疗公司 2024-12-10 CN disclosed